|
1）Tsai FY, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994; 371: 221-6
|
|
|
|
2）Rodrigues NP, Boyd AS, Fugazza C, et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood. 2008; 112: 4862-73
|
|
|
|
|
|
3）Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011; 118: 2653-5
|
|
|
|
|
|
4）Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood. 2011; 118: 2656-8
|
|
|
|
|
|
5）Hahn CN, Chong CE, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011; 43: 1012-7
|
|
|
|
|
|
6）Ostergaard P, Simpson MA, Canmell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011; 43: 929-31
|
|
|
|
|
|
7）Micol JB, Abdel-Wahab O. Collaborating constitutive and somatic genetic events in myeloid malignancies: ASXL1 mutations in patients with germline GATA2 mutations. Haematologica. 2014; 99: 201-3
|
|
|
|
|
|
8）West RR. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica. 2014; 99: 276-81
|
|
|
|
|
|
9）Fujiwara T, Fukuhara N, Funayama R, et al. Identification of acquired mutations by whole-genome sequencing in GATA-2 deficiency evolving into myelodysplasia and acute leukemia. Ann Hematol. 2014; 93: 1515-22
|
|
|
|
|
|
10）Dickinson RE, Milne P, Jardine L, et al. The evolution of cellular deficiency in GATA2 mutation. Blood. 2014; 123: 863-74
|
|
|
|
|
|
11）Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014; 123: 809-21
|
|
|
|
|
|
12）Ganapathi KA, Townsley DM, Hsu AP, et al. GATA2 deficiency-asociated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 2015; 125: 56-70
|
|
|
|
|
|
13）Grossman J. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Biol Blood Marrow Transplant. 2014; 20: 1940-8
|
|
|
|
|
|
14）Haferlach T. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014; 28: 241-7
|
|
|
|
|
|
15）Wang X. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies. Haematologica. 2015 May 28. pii: haematol. 2015. 127092. [Epub ahead of print]
|
|
|
|
|
|
16）Greif PA, Dufour A, Konstandin NP, et al. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood. 2012; 120: 395-403
|
|
|
|
|
|
17）Shih AH, Jiang Y, Meydan C, et al. Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia. Cancer Cell. 2015; 27: 502-15
|
|
|
|
|
|
18）Celton M, Forest A, Gosse G, et al. Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia. Leukemia. 2014; 28: 1617-26
|
|
|
|
|
|
19）Yamazaki H, Suzuki M, Shimizu R, et al. A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(398q21; q26) by activating EVI1 expression. Cancer Cell. 2014; 25: 415-27
|
|
|
|
|
|
20）Tong Q, Dalgin G, Xu H, et al. Function of GATA transcription factors in preadipocyte-adipocyte transition. Science. 2000; 290: 134-8
|
|
|
|
|
|
21）Kamata M, Okitsu Y, Fujiwara T, et al. GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells. Haematologica. 2014; 99: 1686-96
|
|
|
|
|
|
22）Voehringer D. Protective and pathological roles of mast cells and basophils. Nat Rev Immunol. 2013; 13: 362-75
|
|
|
|
|
|
23）Harigae H, Takahashi S, Suwabe N, et al. Differential roles of GATA-1 and GATA-2 in growth and differentiation of mast cells. Genes Cells. 1998; 3: 39-50
|
|
|
|
|
|
24）Walsh JC, DeKoter RP, Lee HJ, et al. Cooperative and antagonistic interplay between PU. 1 and GATA-2 in the specification of myeloid cell fates. Immunity. 2002; 17: 665-76
|
|
|
|
|
|
25）Sasaki H, Kurotaki D, Osato N, et al. Transcription factor IRF8 plays a critical role in the development of murine basophils and mast cells. Blood. 2015; 125: 358-69
|
|
|
|
|
|
26）Li Y, Qi X, Liu B, et al. The STAT5-GATA2 pathway is critical in basophil and mast cell differentiation and maintenance. J Immunol. 2015; 194: 4328-38
|
|
|
|
|
|
27）Ohmori S, Moriguchi T, Noguchi Y, et al. GATA2 is critical for the maintenance of cellular identity in differentiated mast cells derived from mouse bone marrow. Blood. 2015; 125: 3306-15
|
|
|
|
|